Market Size in 2024: USD 319.5 Million

Market Forecast in 2033: USD 1,924.5 Million

Market Growth Rate: 20.43% (2025-2033)

According to the latest report by IMARC Group, the Japan digital therapeutics market size reached USD 319.5 million in 2024. Looking forward, IMARC Group expects it to reach USD 1,924.5 million by 2033, exhibiting a CAGR of 20.43% from 2025 to 2033.

Download a Sample PDF of This Report:  https://www.imarcgroup.com/japan-digital-therapeutics-market/requestsample

Japan Digital Therapeutics Industry Trends and Drivers

The prescription SaMD pathway to routine clinical use in Japan is a key driver of the DTx sector. This stems from consensus that G-teki (Software as a Medical Device) is not widely commercially reimbursed. The path from pilot to routine clinical use is supported by growing clinical evidence across a wide range of behavioral and chronic conditions including smoking cessation and hypertension. Evidence-based DTx are regulated as single software medical devices of class 1 to 4, or software as a medical device (SaMD), when pre-consultation options with the FDA are available. Payer reimbursement may be influenced by functional product value, product cost inputs, cost offsets, and health economic impact. Policy momentum may include SaMD Review and associated consultative reviews, easing faster drug reviews and reducing drug lag, post-market surveillance activities, cybersecurity requirements and real-world evidence (RWE) for SaMD, use of a common data-governance framework, pooling together connected therapies.

Japan Digital Therapeutics Market Segmentation

The market report offers a comprehensive analysis of the segments, highlighting those with the largest Japan digital therapeutics market share. It includes forecasts for the period 2025-2033 and historical data from 2019-2024 for the following segments.

By Application:

Diabetes

Obesity

CVD

CNS Disease

Respiratory Diseases

Smoking Cessation

Others

By End Use:

Patients

Providers

Payers

Employers

Others

Regional Insights:

Kanto Region

Kansai/Kinki Region

Central/Chubu Region

Kyushu-Okinawa Region

Tohoku Region

Chugoku Region

Hokkaido Region

Shikoku Region

Request a Customized Report for Deeper Insights:  https://www.imarcgroup.com/request?type=report&id=19617&flag=E

Competitive Landscape

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant. Additionally, the report features detailed profiles of all major companies in the Japan digital therapeutics industry.

Key Highlights of the Report

Market Performance (2019-2024)

Market Outlook (2025-2033)

COVID-19 Impact on the Market

Porter’s Five Forces Analysis

Strategic Recommendations

Historical, Current, and Future Market Trends

Market Drivers and Success Factors

SWOT Analysis

Structure of the Market

Value Chain Analysis

Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive